User:Bossman42/sandbox

Epidemiological studies have been emphasized in the western part of Africa, particularly in southern Cameroon, where it is endemic. A study done by the Research Foundation in Tropical Diseases and Environment in 2002, with a sample of 1458 persons spanning across 16 different villages. It was discovered that Loa Loa was present in these villages ranging from 2.22% to 19.23% of the population, with it being slightly more prevalent in men.

In Cameroon and surrounding countries there has been an increase in prevalence associated with the distribution of ivermectin, which is used to prevent the infection of onchocerciasis that is also very prevalent in the same region. Patients with Loa Loa that are treated with Ivermectin have extreme adverse effects and in the most severe cases, death has occurred. Therefore, a prevalence mapping system was created, REMO, to determine which areas to distribute the ivermectin based on low or no Loa Loa prevalence. The area that was discovered to be the most overlapping was the area where Cameroon and the Democratic Republic of Congo overlap.